TIM MOELLER: Open Payments
NPI 1669119301 · HINSDALE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,038 in 20 payments from 10 companies in 2025. Trend: 2023 $1,085 · 2024 $711 · 2025 $2,038
Consulting: $1,125Food & beverage: $813Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $1,521 |
| Novartis Pharmaceuticals Corporation | 2 | $140 |
| Regeneron Healthcare Solutions, Inc. | 1 | $115 |
| GENZYME CORPORATION | 3 | $77 |
| Lilly USA, LLC | 3 | $68 |
| ABBVIE INC. | 2 | $47 |
| Arcutis Biotherapeutics, Inc. | 1 | $21 |
| PFIZER INC. | 1 | $18 |
| Amgen Inc. | 1 | $17 |
| Incyte Corporation | 1 | $14 |
Products named: TREMFYA, DUPIXENT, RINVOQ, TALTZ, Rhapsido, EBGLYSS, Zoryve, EUCRISA.
Industry payments across IL — which companies pay providers there.
